BMC MEDICAL IMAGING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2022-10-21 刘培青

审稿速度:2.0 | 投稿命中率:25.0
经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2023-05-12 ms3000001382747008 来自四川省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：影像;偏重临床
经验分享：1月12日投稿
3月23日 under peer review
4月24日大修
4月30日修回
5月10日小修
5月11日修回
过程确实很漫长，目前一直在技术审查，希望是好的结果吧。

28 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2023-10-02 ms9000001126241573 来自辽宁省

我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2023-07-19 ms4000001631029963 来自浙江省

审稿速度:3.0
经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2018-05-23 medseed

审稿速度:6.0 | 投稿命中率:25.0
经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语

356 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2023-02-11 ms7000001196456992 来自新疆

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：影像
经验分享：快三个月了一点消息都没有

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2022-10-21 Louis88

审稿速度:6.0 | 投稿命中率:25.0
经验分享：遥遥无期

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2022-10-06 ms6275208486500390

审稿速度:2.0 | 投稿命中率:75.0
经验分享：一月份投稿五月份见刊

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2022-06-10 ms9000001233266300

现在还接受个案报道吗？

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2095216, encodeId=f3222095216a3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：用Spinger Nature这个平台，一开始4个审稿人，后来8个，现在10个，也没收到审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=刘培青, createdTime=Fri Oct 21 16:56:12 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132993, encodeId=a40d213299368, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：影像;偏重临床 经验分享：1月12日投稿 3月23日 under peer review 4月24日大修 4月30日修回 5月10日小修 5月11日修回 过程确实很漫长，目前一直在技术审查，希望是好的结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c46148244, createdName=ms3000001382747008, createdTime=Fri May 12 20:13:26 CST 2023, time=2023-05-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160633, encodeId=14102160633f9, content=我想问一下，发了邮件说有技术问题，点击去网页又不知道哪里能修改怎么办呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c15618406, createdName=ms9000001126241573, createdTime=Mon Oct 02 15:35:03 CST 2023, time=2023-10-02, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148853, encodeId=91572148853c4, content=审稿速度:3.0 经验分享：二审一直只有一个审稿人，2个多月拒稿，四个审稿人只有一个拒绝，其他都同意......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19578578291, createdName=ms4000001631029963, createdTime=Wed Jul 19 21:05:44 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=556360, encodeId=cc7d5563601c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审5个月催稿然后瞬间回复7个小时瞬间拒稿无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/08/934ee63f3df431ba79b745576ad25f3f.jpg, createdBy=65df2142606, createdName=medseed, createdTime=Wed May 23 00:00:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114116, encodeId=aefe211411626, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：影像 经验分享：快三个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c748474282, createdName=ms7000001196456992, createdTime=Sat Feb 11 15:21:10 CST 2023, time=2023-02-11, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2095220, encodeId=2d602095220de, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：遥遥无期, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3ce5484440, createdName=Louis88, createdTime=Fri Oct 21 17:11:35 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091992, encodeId=81e1209199211, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一月份投稿五月份见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/GcAobrQM3uzTcpwdcIO3l5WkQSa3g3yk8oMDXpBYGO0Q54yDmCC98B9qCVMlOricvMq9O0oKvkRt3kpicvpNRPGg/132, createdBy=2d0c5267045, createdName=ms6275208486500390, createdTime=Thu Oct 06 00:14:31 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225730, encodeId=49371225e30bb, content=现在还接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20118165837, createdName=ms9000001233266300, createdTime=Fri Jun 10 22:35:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199457, encodeId=261f119945e99, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：心血管临床方向 经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1a15242236, createdName=147c2ba4m98暂无昵称, createdTime=Fri Mar 04 19:37:45 CST 2022, time=2022-03-04, status=1, ipAttribution=)]

2022-03-04 147c2ba4m98暂无昵称

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：心血管临床方向
经验分享：速度比较慢，21年8月投稿，22年2月底接收，中间一次大修后两月接收，第一次审稿有3-5个审稿人。

54 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务